Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Chest

Retrieve available abstracts of 31 articles:
HTML format



Single Articles


    September 2025
  1. SINHA P, Karoly M, Padmapriyadarsini C, Paradkar M, et al
    Contribution of Key Comorbidities to Unfavorable Treatment Outcomes among Adults with Drug-sensitive Pulmonary Tuberculosis in India: a Prospective Cohort Analysis.
    Chest. 2025 Sep 10:S0012-3692(25)05171-2. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available


    July 2025
  2. CHEN C, Xue H, Horsburgh CR, Amour M, et al
    Trajectories of Interferon-Gamma Release Assay Results Over 2 Years in Independent Cohorts From China, South Africa, Tanzania, and the United States.
    Chest. 2025;168:33-42.
    PubMed     Abstract available


    May 2025
  3. JIANG J, Rao Y, Liu C, Chang SJ, et al
    A 7-Year-Old Girl With Multiple Pulmonary Nodules.
    Chest. 2025;167:e161-e165.
    PubMed     Abstract available


  4. DONOVAN FM, Thompson GR 3rd, Blair JE, Johnson RH, et al
    Managing Cavitary Coccidioidomycosis Expert Opinions for Improving Patient Outcomes.
    Chest. 2025;167:1311-1320.
    PubMed     Abstract available


    April 2025
  5. AGARWAL R, Muthu V, Sehgal IS
    Evaluation for Allergic Bronchopulmonary Aspergillosis in Patients With Bronchiectasis.
    Chest. 2025;167:e143.
    PubMed    


  6. CARTER C, Shah A
    The Fungal Frontier: Understanding the Impact of Aspergillus in Bronchiectasis.
    Chest. 2025;167:914-916.
    PubMed    


    March 2025
  7. LEE J, Park SJ, Kim S, Lee HN, et al
    Isolation of Genetically Distinct Strains Within the Same Species During Treatment of Mycobacterium Avium Complex Pulmonary Disease.
    Chest. 2025;167:675-685.
    PubMed     Abstract available


    February 2025
  8. JAIN R, Peng G, Lee M, Keller A, et al
    Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy.
    Chest. 2025;167:348-361.
    PubMed     Abstract available


  9. WAHAB A, Sanborn D, Vergidis P, Razonable R, et al
    Diagnosis and Prevention of Invasive Fungal Infections in the Immunocompromised Host.
    Chest. 2025;167:374-386.
    PubMed     Abstract available


    January 2025
  10. KIM H, Jo E, Kim J, Lee N, et al
    Diagnostic Performance of the Modified Lung-RADS in a Tuberculosis-endemic Country: The Korean National Lung Cancer Screening Program.
    Chest. 2025 Jan 28:S0012-3692(25)00133-3. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available


  11. JIANG Y, Huang X, Zhou H, Wang M, et al
    Clinical Characteristics and Prognosis of Patients With Severe Pneumonia With Pneumocystis jirovecii Colonization: A Multicenter, Retrospective Study.
    Chest. 2025;167:54-66.
    PubMed     Abstract available


    December 2024
  12. EVEN-DAR R, Raz I, Brodsky M, Stein N, et al
    Non- Tuberculous mycobacterial infection and pulmonary disease In Northern Israel: a focus on M. simiae.
    Chest. 2024 Dec 2:S0012-3692(24)05600-9. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available


    November 2024
  13. HOLTROP M, Cosmich S, Lee M, Keller A, et al
    Sex Differences After Treatment With Ivacaftor in People With Cystic Fibrosis.
    Chest. 2024;166:951-962.
    PubMed     Abstract available


    October 2024
  14. CHOI H, Hughes C, Eke Z, Shuttleworth M, et al
    Clinical Efficacy of Serum Anti-glycopeptidolipid-core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study.
    Chest. 2024 Oct 25:S0012-3692(24)05418-7. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available


  15. POLLOCK J, Goeminne PC, Aliberti S, Polverino E, et al
    Aspergillus serology and clinical outcomes in patients with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
    Chest. 2024 Oct 24:S0012-3692(24)05400-X. doi: 10.1016/j.chest.2024.06.3843.
    PubMed     Abstract available


  16. GABORIT B, Lecuyer R, Issa N, Camou F, et al
    Should We Reconsider Pneumocystis Pneumonia Presentation and Treatment According to Its Underlying Disease?: An Unsupervised Cluster Analysis of a Retrospective Multicenter Study.
    Chest. 2024;166:708-711.
    PubMed    


  17. JOEAN O, von Eynern LP, Welte T, Einecke G, et al
    Clinical Features, Diagnostics, Etiology, and Outcomes of Hospitalized Solid Organ Recipients With Community-Acquired Pneumonia: A Retrospective Cohort Analysis.
    Chest. 2024;166:697-707.
    PubMed     Abstract available


    September 2024
  18. LEE JK, Kim S, Chong YP, Lee HJ, et al
    The Association Between Sputum Culture Conversion and Mortality in Cavitary Mycobacterium avium Complex Pulmonary Disease.
    Chest. 2024;166:442-451.
    PubMed     Abstract available


  19. HYUNG K, Kim SA, Kim JY, Kwak N, et al
    Rates and Risk Factors of Progression in Patients With Nontuberculous Mycobacterial Pulmonary Disease: Secondary Analysis of a Prospective Cohort Study.
    Chest. 2024;166:452-460.
    PubMed     Abstract available


    August 2024
  20. PEDERSEN AA, Lokke A, Floe A, Ibsen R, et al
    Nationwide Increasing Incidence of Nontuberculous Mycobacterial Diseases Among Adults in Denmark: Eighteen Years of Follow-Up.
    Chest. 2024;166:271-280.
    PubMed     Abstract available


    July 2024
  21. BAI AD, Srivastava S, Digby GC, Girard V, et al
    Anaerobic Antibiotic Coverage in Aspiration Pneumonia and the Associated Benefits and Harms: A Retrospective Cohort Study.
    Chest. 2024;166:39-48.
    PubMed     Abstract available


  22. FELZER JR, Montgomery AJ, LeMahieu AM, Finney Rutten LJ, et al
    Disparities in Influenza, Pneumococcal, COVID-19 Vaccine Coverage in High-Risk Adults Aged 19 to 64 Years in Southeastern Minnesota, 2010-2021.
    Chest. 2024;166:49-60.
    PubMed     Abstract available


    June 2024
  23. SCHERGER SJ, Kalil AC
    Changes in the Mortality Rate and Epidemiology of Pneumocystis Pneumonia Require Novel Approaches to Clinical Care.
    Chest. 2024;165:1273-1275.
    PubMed    


  24. LECUYER R, Issa N, Camou F, Lavergne RA, et al
    Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying Disease: A Retrospective Multicenter Study.
    Chest. 2024;165:1319-1329.
    PubMed     Abstract available


    May 2024
  25. ZWEIJPFENNING SMH, Aarnoutse R, Boeree MJ, Magis-Escurra C, et al
    Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial.
    Chest. 2024;165:1082-1092.
    PubMed     Abstract available


    March 2024
  26. WALKER MK, Kadri SS
    Generalizing the Use of a Procalcitonin-Guided Antibiotic Algorithm to a New Era of SARS-CoV-2 Infection.
    Chest. 2024;165:e85-e86.
    PubMed    


  27. THIZY G, Flahault A, Scemla A, Roux O, et al
    Legionnaires Disease in Solid Organ Transplant Recipients: A Decade-Long Nationwide Study in France.
    Chest. 2024;165:507-520.
    PubMed     Abstract available


  28. YAN M, Fraser B, McArthur E, Mehrabi M, et al
    External Validation of the BACES Score in Canadian Patients With Nontuberculous Mycobacterial Pulmonary Disease.
    Chest. 2024;165:521-528.
    PubMed     Abstract available


  29. AZAR MM
    A Diagnostic Approach to Fungal Pneumonia: An Infectious Diseases Perspective.
    Chest. 2024;165:559-572.
    PubMed     Abstract available


    December 2023
  30. NAEGER S, Pool V, Macina D
    Increased burden of pertussis among adolescents and adults with asthma or COPD in the US, 2007-2019.
    Chest. 2023 Dec 19:S0012-3692(23)05934-2. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  31. KU JH, Henkle E, Carlson KF, Marino M, et al
    Tolerability outcomes of ATS/IDSA guideline-recommended multi-drug antibiotic treatment for Mycobacterium avium complex pulmonary disease in U.S. Medicare beneficiaries with bronchiectasis.
    Chest. 2023 Dec 10:S0012-3692(23)05846-4. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.